ATE456798T1 - Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret) - Google Patents

Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret)

Info

Publication number
ATE456798T1
ATE456798T1 AT06816778T AT06816778T ATE456798T1 AT E456798 T1 ATE456798 T1 AT E456798T1 AT 06816778 T AT06816778 T AT 06816778T AT 06816778 T AT06816778 T AT 06816778T AT E456798 T1 ATE456798 T1 AT E456798T1
Authority
AT
Austria
Prior art keywords
daret
molecular
interactivity
depolarization
cellular
Prior art date
Application number
AT06816778T
Other languages
English (en)
Inventor
Marcella Gilmore
Dudley Williams
Lance Steward
Kei Roger Aoki
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37806796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE456798(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE456798T1 publication Critical patent/ATE456798T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6445—Measuring fluorescence polarisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Measurement Of Resistance Or Impedance (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06816778T 2005-10-12 2006-10-11 Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret) ATE456798T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72651505P 2005-10-12 2005-10-12
PCT/US2006/039846 WO2007047342A1 (en) 2005-10-12 2006-10-11 Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)
US11/548,411 US7998749B2 (en) 2005-10-12 2006-10-11 Assays of molecular or subcellular interactivity using depolarization after resonance transfer energy (DARET)

Publications (1)

Publication Number Publication Date
ATE456798T1 true ATE456798T1 (de) 2010-02-15

Family

ID=37806796

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09010300T ATE555387T1 (de) 2005-10-12 2006-10-11 Tests der molekularen oder subzellulären nähe unter verwendung von depolarisierung nach resonanzenergietransfer (daret)
AT06816778T ATE456798T1 (de) 2005-10-12 2006-10-11 Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT09010300T ATE555387T1 (de) 2005-10-12 2006-10-11 Tests der molekularen oder subzellulären nähe unter verwendung von depolarisierung nach resonanzenergietransfer (daret)

Country Status (9)

Country Link
US (1) US7998749B2 (de)
EP (2) EP1934610B1 (de)
JP (2) JP2009521666A (de)
AT (2) ATE555387T1 (de)
AU (1) AU2006304151B2 (de)
CA (1) CA2602972C (de)
DE (1) DE602006012072D1 (de)
ES (1) ES2338368T3 (de)
WO (1) WO2007047342A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9617671D0 (en) * 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US20080064054A1 (en) * 2001-08-28 2008-03-13 Ester Fernandez-Salas Fluorescence resonance energy transfer (fret) assays for clostridial toxin activity
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
US8999666B2 (en) * 2006-08-09 2015-04-07 Intrexon Corporation PKC ligands and polynucleotides encoding PKC ligands
CN101932936B (zh) 2007-09-14 2016-04-27 拜奥麦迪逊公司 利用切割序列和间隔子的共振能量转移测定
MY155049A (en) 2008-03-14 2015-08-28 Allergan Inc Immuno-based botolinum toxin serotype a activity assay
KR101604515B1 (ko) * 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
US8993715B2 (en) 2009-07-06 2015-03-31 Canon Kabushiki Kaisha Labeled protein and method for obtaining the same
US20110312798A1 (en) * 2010-06-17 2011-12-22 Geneasys Pty Ltd Test module with inbuilt lancet
EP2798077A2 (de) 2011-12-31 2014-11-05 Allergan, Inc. Hochempfindlicher zellbasierter test für den nachweis der anwesenheit von aktivem botulinum-neurotoxin-serotyp-a
CN105996968A (zh) * 2016-05-09 2016-10-12 南京琦光光电科技有限公司 医疗内窥镜用led光源及光谱设计方法
EP4211508B1 (de) * 2020-09-14 2025-11-26 Singular Genomics Systems, Inc. Verfahren und systeme zur mehrdimensionalen bildgebung

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211762A (en) 1978-01-26 1980-07-08 Huggins Keith G Specific binding assay techniques
DE3168691D1 (en) 1980-11-07 1985-03-14 Technicon Instr Immunoassay of proteins
US4680258A (en) 1981-03-24 1987-07-14 Sloan-Kettering Institute For Cancer Research Process for sex determination in man by use of monoclonal antibodies to the H-Y antigen
US4427783A (en) 1981-12-14 1984-01-24 Hoffmann-La Roche Inc. Immunoassay of thymosin α1
US4628027A (en) 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
WO1990004788A1 (en) * 1988-10-28 1990-05-03 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5962637A (en) * 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
US6596522B2 (en) * 1997-05-08 2003-07-22 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US6342379B1 (en) * 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
US5661035A (en) * 1995-06-07 1997-08-26 The Regents Of The University Of California Voltage sensing by fluorescence resonance energy transfer
US6358709B1 (en) * 1995-12-07 2002-03-19 Diversa Corporation End selection in directed evolution
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
JP3255293B2 (ja) * 1997-09-05 2002-02-12 松下電器産業株式会社 蛍光偏光法
US6444421B1 (en) * 1997-11-19 2002-09-03 The United States Of America As Represented By The Department Of Health And Human Services Methods for detecting intermolecular interactions in vivo and in vitro
US7101681B1 (en) 1997-11-21 2006-09-05 Amgen, Inc. Nuclear hormone receptor drug screens
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
DE69941085D1 (de) * 1998-07-17 2009-08-20 Univ Maryland Manipulierte proteine zum analyten nachweis
DE19860833C1 (de) 1998-12-30 2000-09-07 Albrecht E Sippel Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen
AU2849800A (en) * 1999-01-15 2000-08-01 Ljl Biosystems, Inc. Methods and apparatus for detecting polynucleotide hybridization
US6972198B2 (en) 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using protein binding partners
JP2000333681A (ja) * 1999-05-27 2000-12-05 Nec Corp タンパク質分解酵素切断配列を含有するタンパク質分解酵素用基質及びその発現用ベクター
EP1203816A4 (de) 1999-07-08 2004-12-08 Fujisawa Pharmaceutical Co Amyloid beta-protein agglutination kontrollierender faktor
US6325899B1 (en) * 2000-03-10 2001-12-04 Action Caps, Llc Disposable and recyclable intermediates for use in electrostatic coating processes
EP1195604A1 (de) * 2000-09-29 2002-04-10 Warner-Lambert Company Verfahren und Zusammensetzungen zum Screenen von Modulatoren von Lipidkinasen
US7208285B2 (en) 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US20080064054A1 (en) * 2001-08-28 2008-03-13 Ester Fernandez-Salas Fluorescence resonance energy transfer (fret) assays for clostridial toxin activity
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
AU2002363530A1 (en) * 2001-11-07 2003-05-19 Sensor Technologies Llc Method of identifying energy transfer sensors for analytes
JP2005513439A (ja) * 2001-12-17 2005-05-12 パウダージェクト リサーチ リミテッド 診断用センシング装置
US6942987B2 (en) * 2002-05-15 2005-09-13 Pharmacopeia Drug Discovery, Inc. Methods for measuring kinase activity
US6713262B2 (en) * 2002-06-25 2004-03-30 Agilent Technologies, Inc. Methods and compositions for high throughput identification of protein/nucleic acid binding pairs
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
JP4214206B2 (ja) * 2002-12-10 2009-01-28 独立行政法人理化学研究所 Ｆｒｅｔを利用した蛍光指示薬
US6969196B2 (en) * 2003-03-07 2005-11-29 Exopack-Technology, Llc Bag having reclosable seal and associated methods
JP2005017282A (ja) * 2003-05-30 2005-01-20 Olympus Corp 受光ユニットおよびそれを含む測定装置
US7408640B2 (en) * 2003-11-05 2008-08-05 The United States Of America As Represented By The Secretary Of The Navy Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids
EP2502930B1 (de) * 2003-12-19 2016-06-29 Wisconsin Alumni Research Foundation Verfahren und zusammensetzungen zum nachweis von botulinum-neurotoxin
AU2005216547B2 (en) * 2004-02-24 2009-03-12 Allergan, Inc. Botulinum toxin screening assays
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
ATE470857T1 (de) * 2005-04-05 2010-06-15 Allergan Inc Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität

Also Published As

Publication number Publication date
US7998749B2 (en) 2011-08-16
EP2131195A1 (de) 2009-12-09
EP1934610A1 (de) 2008-06-25
EP2131195B1 (de) 2012-04-25
AU2006304151A1 (en) 2007-04-26
WO2007047342A1 (en) 2007-04-26
US20070275477A1 (en) 2007-11-29
CA2602972A1 (en) 2007-04-26
AU2006304151B2 (en) 2012-01-19
ATE555387T1 (de) 2012-05-15
JP2009521666A (ja) 2009-06-04
DE602006012072D1 (de) 2010-03-18
EP1934610B1 (de) 2010-01-27
JP2013174595A (ja) 2013-09-05
ES2338368T3 (es) 2010-05-06
CA2602972C (en) 2013-09-24

Similar Documents

Publication Publication Date Title
DE602006012072D1 (de) Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret)
ATE394677T1 (de) Fret proben und verfahren zur erkennung aufeinander einwirkeneden moleküle
DE60232323D1 (de) Verbessertes verfahren zum nachweis von atp
ATE506368T1 (de) Pyridin-boronsäure-quencher zur verwendung in analytsensoren
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
DE602006014812D1 (de) Lostridientoxinaktivität
NZ596163A (en) Diagnostic devices and related methods
DE60009661D1 (de) Methode zum nachweis von veränderungen zellulärer komponenten
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
DE602005026273D1 (de) Vorrichtungen und verfahren für abnahme, lagerung und transport von biologischen proben
CY1107130T1 (el) Διαταξη και μεθοδος για την αναλυση πληροφοριακου σηματος.
NO20062690L (no) Fremgangsmate for a karakterisere et frakturreservoar ved hjelp av seismiske refleksjonsamplituder
RU2011130535A (ru) Анализ тропонина i с применением магнитных меток
CY1107021T1 (el) Μεθοδος προσδιορισμου της ποσοτητας εκμαγειου νουκλεϊνικου οξεος που υπαρχει σε ενα δειγμα
DE60239940D1 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
CY1112090T1 (el) Μεθοδος για ανιχνευση βιολογικων οργανισμων με χρηση σκεδασης raman
ATE431932T1 (de) Markierungsverfahren zur ausschussmarkierung von testelementen
ATE541216T1 (de) Fluoreszenztestverfahren
DK1915626T3 (da) Apoptosesensitivitet mod Apo2L/TRAIL ved testning for GalNac-T14-ekspression i celler/væv
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
UA107789C2 (en) Method based on biomarkers designed to monitor treatment
DE602005025043D1 (de) Saccharose-biosensoren und verwendungsverfahren dafür
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties